Submitted Successfully!
Thank you for your contribution! You can also upload a video entry related to this topic through the link below:
Check Note
Ver. Summary Created by Modification Content Size Created at Operation
1 -- 2222 2022-04-19 11:26:46 |
2 format correction -10 word(s) 2212 2022-04-20 03:02:20 |
Anemia in Pregnant Women and Children
Upload a video

 Globally, anemia is still a public health issue faced by people in low and high-income countries. Anemia is a condition in which a person’s hemoglobin level is less than normal (below 11 g/dL for pregnant women and children aged 6–59 months). This study gives an overview of published scientific articles related to the prevalence, nutritional indicators, and social determinants of anemia in pregnant women and children aged 6 to 59 months living in Mozambique and Portugal. 

anemia pregnant women children Mozambique Portugal
Subjects: Others
View Times: 266
Revisions: 2 times (View History)
Update Date: 20 Apr 2022
Table of Contents

    1. Introduction

    Globally, it is still a public health issue faced by people in both low- and high-income countries and is a concern for adolescent girls, women of reproductive age (particularly during pregnancy), and children in the first years of life [1][2]. It impairs health and well-being in women and increases the risk of maternal and neonatal adverse outcomes [3][4]. Physiologic anemia is the most common cause of anemia in the neonatal period, being more pronounced in preterm infants compared with term infants, accounting that half of the cases are due to iron deficiency. In women, it may develop because of prenatal, perinatal (at delivery), or postpartum hemorrhage [5]. Iron deficiency during pregnancy can persist through lactation, although it may be partially alleviated because of lactational amenorrhea. Poor-quality diets can lead to iron deficiency anemia; on another hand, food and nutrition issues are determinants of iron supplementation and health at all levels, through structural macro-level policies, social conditions, or circumstances of daily life [6]. Worldwide, in 2019, anemia prevalence was 22.8% accounting for a total of 1.74 billion cases. In the same year, the prevalence was highest among children under five years (with a combined prevalence of 39.7%). Globally, 54.1% of anemia cases were mild, 42.5% were moderate, and 3.4% were severe. The regions with the highest-burden were South Asia, Western, and Central Sub-Saharan Africa [7]. According to the Global Nutrition Report, anemia affects 613.2 million (32.8% prevalence) adolescent girls and women aged 15 to 49 years, being its prevalence markedly higher in pregnant (35.3 million, 40.1%) than non-pregnant (577.9 million, 32.5%) adolescent girls and women [1].
    According to data from the last Demographic Health Survey, in Mozambique, about 54.0% of women of reproductive age (15–49 years) and 69.0% of children aged 6–59 months had anemia [8]. It is estimated that in 2015, of a total of 388,345 cases of anemia, diarrhea, fever, and respiratory infections, only 45.2% received adequate health care [9]. Data from the EMPIRE study show that in 2014, the prevalence of anemia in the Portuguese population was 20.4%, and this scenario was classified as a public health problem. Of these cases, the vast majority (84.0%) were unaware of having anemia and only 2.0% of the Portuguese population received some form of treatment for this condition [10]. Estimates for the year 2019 indicated that about 45.8% of pregnant women aged 15–49 years living in Mozambique and 19.4% of pregnant women aged 15–49 years living in Portugal have anemia [11]. Anemia prevalence estimates were 68.2% and 14.3% in children aged 6–59 months living in Mozambique and Portugal, respectively [12]. Among the global nutrition goals of the World Health Organization for 2025, set by the World Health Assembly in 2012 and 2013, set to end malnutrition are a 50.0% reduction in anemia in women of reproductive age and a 30.0% reduction in low birth weight [13][14]. The prevention and treatment of anemia in women of childbearing age can help to reduce the low birth weight, perinatal and maternal mortality, and later diseases throughout life [3].

    2. Anemia and Iron Deficiency Anemia (IDA) Prevalence

    Global and regional anemia and iron deficiency anemia prevalence data were reported in five studies, but only two studies reported Mozambique and Portugal-specific data [15][16][17][18][19]. In 2013, the prevalence of iron deficiency cases (by thousands) was of about 5193.9 (4985.7–5442.7) and of about 1205.7 (1180.2 to 1227.5), in Mozambique and Portugal, respectively [17]. The absence of postpartum anemia in pregnant women with vaginal deliveries who were admitted in labor was also reported in one study trial conducted in Portugal during the years 2006 and 2007 [20]. A review reported that in 2005, the prevalence of anemia was severe (≥40.0%) among Mozambican children of preschool age (0–5 years) [15]. Nonetheless, for both countries, data on anemia and iron deficiency in pregnant women and children aged 6 to 59 months old are either outdated or remain unclear as the findings hereby reported were not disaggregated into these specific subgroups.

    3. Malaria and HIV/AIDS

    Two study trials that included 5469 pregnant women conducted between 1987–2013 in Mozambique, showed that mefloquine was more efficacious than sulfadoxine-pyrimethamine in HIV-uninfected women or daily cotrimoxazole prophylaxis in HIV-infected pregnant women for prevention of malaria infection and was associated with lower risk of maternal anemia (RR 0.84, 95% CI 0.76 to 0.94), no adverse effects on pregnancy outcomes (stillbirths and abortions), and no effects on low birth weight and prematurity. The high proportion of mefloquine-related adverse events constitutes an important barrier to its effectiveness for malaria preventive treatment in pregnant women [21]. Two other trials carried out between 2004–2008 in Mozambique found a large effect in reducing the risk of cord blood anemia (RR 0.49, 95% CI 0.30 to 0.80), and increase in mean cord packed cell volume (MD 1.01%, 95% CI 0.05 to 1.97) [22]. Nonetheless, the possible effects or benefits of routine malaria chemoprevention, hookworm and HIV/AIDS prevention and treatment strategies, and hookworms on reducing the risk of maternal anemia and negative pregnancy outcomes are still not well documented, in particular in provinces of Mozambique with the highest burden of malnutrition and food insecurity. Unsurprisingly, for Portugal comparatively to Mozambique, which has been facing a burden of malaria and HIV/AIDS for several years, data remain unclear.

    4. Anemia in Pregnant Women and Children Living in Mozambique and Portugal

    Evidence indicates that anemia plays a relevant role in disability and life imbalances in pregnant women and children under five years of age in Mozambique compared with Portugal [17][18][19]. These findings are consistent with previous studies in Portugal that showed a low prevalence of maternal anemia in the first half of pregnancy. However, careful attention needs to be paid as these studies were conducted with Portuguese women in the 20th week of pregnancy, whereas anemia prevalence often tends usually to be higher in late pregnancy, in women without iron supplementation [23]. Researcher's findings related to Mozambique agree well with previous reports that suggest that researchers are faced with a population of mothers with low iron stores, conditioning the hemoglobin values of infants in the first months of life [24]. Adding to this are many contextual cultural and socio-economic factors that may contribute to high levels of anemia throughout infancy in Mozambican children.
    A growing body of literature showed that adolescents are at risk of iron deficiency because of their high iron requirements during the growth spurt period, particularly in girls for whom the start of menstruation leads to iron losses [25][26][27][28]. Concerning adolescent women, iron deficiency anemia is still a public health problem in both countries, since the data indicate that it is a risk factor for disadjusted life years [29][30]. The results found in Portuguese adolescent girls, also coincide with those reported in the last statistics of Portugal that showed prevalence rates of 9.0% in adolescent girls aged 12–15 years and 16.0% in adolescent girls aged 16–19 years [31]. Reports from previous years from the HELENA Study showed that the overall proportion of iron depletion among adolescents was 17.6%, being higher in girls compared to boys. By geographical location, rates were higher in Eastern Europe (Pecs, 23%) followed by Northern Europe (Stockholm, 19.0%), Western Europe (17.0% in Ghent and 19.0% in Lille), Central Europe (16.0% in Dortmund and 19.0% in Vienna) and 15.0% in Southern Europe (14.0% in Athens, 17.0% in Heraklion, 19.0% in Rome and 10.0% in Zaragoza) [26]. Other authors reported a prevalence of anemia of 2.6% in Portuguese adolescents living in the city of Porto, being these rates higher in girls (4.1%) compared to boys (1.0%) [25][32]. Nonetheless, these results only allow for statistical comparison of differences in iron status between selected European cities but not between European regions [26]. On the other hand, the findings are similar to those found in Spain, which shows that 15.0% of Spanish adolescents had iron deficiency anemia in a similar period, thus pointing more specifically to iron deficiency anemia as a clinical challenge in the daily practice of medicine at all levels of care [33]. There is evidence to suggest that dietary iron intake may be poor because of inadequate intake during adolescence or due to poor iron intake since infancy. Other factors such as a change in dietary habits by peer influence, eating disorders (refusal to eat, excessive weight-loss diets, and skipping meals), dependence on food that can be prepared rapidly and simply (fast food) can also play a crucial role on iron deficiency [25]. The findings suggest the need for specific attention to adequate dietary intake from infancy up to adolescence particularly for adolescent girls ensuring that their dietary iron intake is adequate to their requirements, agreeing with those results previously reported by De Andrade et al. [25]. Findings here reported related to anemia in Mozambican preschoolers under five years of age are also of huge concern, as other studies conducted in Sub-Saharan Africa showed that anemia persists through later ages of life, being also a burden in elder preschoolers aged 7–15 years [15][34].
    The global burden of diseases in 2015 and 2016 classifies Mozambique as a low social demographic index country (SDI) and Portugal as a high-middle social demographic index country (SDI) [18][19][35]. In the year 2016, iron deficiency anemia was one of the leading causes of YLDs in low-middle-SDI and low-SDI quintiles. Pooled analysis that included among other African countries, neighbor-countries of Mozambique with a similar SDI (such as Tanzania, Eswatini, and Madagascar), showed that the risk of anemia among women living in the lowest wealth quintiles was 25.0% higher than among those in the highest wealth quintile. Women with no education were more likely to be anemic than were those with greater than secondary education. Patterning of anemia by socioeconomic status was also noted for children: a child living in a household in the lowest wealth quintile was 21.0% more likely to be anemic than were those in the highest wealth quintile [15]. Conditional on demographic and socioeconomic factors, the mother’s anemia status was among the strongest predictors of anemia in children [15][36]. Age and gender were the social determinants more analyzed comparatively to indicators such as the years of schooling or wealth index [17][18][19][29]. Previous studies highlighted the relevance of social determinants analysis to better understand the causal association of social determinants and the occurrence of anemia [37]. Despite the relevance of this issue has been studied in other countries hereby mentioned, limited research evidence on anemia’s social and structural determinants prevails for Mozambique and Portugal.
    A gap of information on anemia, other nutritional indicators (in addition to iron deficiency), and social determinants in pregnant women and children between 6 and 59 months of age living in Mozambique and Portugal are highly observed in the overview. Little literature related to anemia; researcher's focus subgroup was also found at Index Medical Portuguese Journals—a Portuguese national database with non-open access. Anemia prevalence among Portuguese pregnant women and Mozambican children under 59 months old was a topic approached in some of the publications found, nonetheless, the majority of studies had its focus on supplementation with iron during pregnancy, preschoolers’ food habits, and case studies interlinked with anemia during infancy [23][24][38][39][40][41][42][43]. More research is required to gather scientific-based evidence that can contribute to improving strategies that allow researchers to achieve the goals established by the World Assembly of WHO of reducing anemia in women of reproductive age, low birth weight, and under-five mortality. Undoubtedly efforts to attain these goals are interlinked to achieving the following Sustainable Development Goals (SDGs): “2.2 End all forms of malnutrition”, “3.1. Reduce global maternal mortality ratio to less than 70 per 100 000 live births by 2030” and “3.2. End preventable deaths of newborns and children under five years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1000 live births and under-5 mortality to at least as low as 25 per 1000 live births, by 2030” [44].
    An opportunity acknowledged by the Universal Health Coverage (UHC) 2030′s platform is that the inclusion of universal health coverage in the SDGs can be a coherent approach to health, allowing the acceleration of equitable and sustainable progress toward universal health coverage and health systems strengthening at global and country levels [45]. Even though both countries which were the focus of the study present huge contextual, geographic, and socioeconomic differences, Mozambique despite some progress (made in previous years) had a remarkably low UHC service coverage index and life expectancy (of 46.0; 61 years) compared with Portugal (of 82.0; 80 years) by the year 2017. External health expenditure was also strikingly higher in Mozambique (62.92) compared with Portugal (0.09) by the year 2018 [45][46]. With this in mind, the best performances in health indicators are clearly observed for Portugal compared with Mozambique where major health (triple burden diseases, infectious illnesses), lack of water, lack of good sanitation, lack of access to health facilities problems, as well as food insecurity still prevails [47]. Nevertheless, Costa et al. showed that throughout Eastern and Southern European countries, including Portugal, population health inequalities prevail across metropolitan areas, generally, with municipalities presenting worse health determinants value scores. Despite geographic disparities in the distribution of value scores of health outcomes between municipalities may not be as evident as expected in Portugal, more specifically in Lisbon, health inequalities still prevail and need to be tackled [48]. As stated by Malta et al. [47], Mozambique and Portugal are both Community of Portuguese Language Countries (CPLP), and the strengthening of network collaborations focused on research, and more specifically on anemia can be of added value to give more visibility to this health issue and to improve health policies and to reinforce strategies aimed to reduce anemia between pregnant women and children under five years living in Mozambique and Portugal.


    1. Global Nutrition Report (GNR). Glossary 2020 Global Nutrition Report—Global Nutrition Report. 2020. Available online: (accessed on 8 May 2021).
    2. Impieri De Souza, A.; Filho, M.B. Diagnóstico e tratamento das anemias carenciais na gestação: Consensos e controvérsias. Rev. Bras. Saúde Matern. Infant 2003, 3, 473–479.
    3. World Health Organization (WHO). What’s at Stake Target: 50% Reduction of Anaemia in Women of Reproductive Age Box 1: What Is Anemia? 2014. Available online: (accessed on 6 May 2021).
    4. Elmardi, K.A.; Adam, I.; Malik, E.M.; Abdelrahim, T.A.; Elhag, M.S.; Ibrahim, A.A.; Babiker, M.A.; Elhassan, A.H.; Kafy, H.T.; Elshafie, A.T.; et al. Prevalence and determinants of anaemia in women of reproductive age in Sudan: Analysis of a cross-sectional household survey. BMC Public Health 2020, 20, 1–12.
    5. Merck Manual of Diagnosis (MSD). Perinatal Anemia—Pediatrics. MSD Manual Professional Edition. 2020. Available online: (accessed on 26 April 2021).
    6. Nagata, J.M.; Gatti, L.R.; Barg, F. Social determinants of iron supplementation among women of reproductive age: A systematic review of qualitative data. Matern. Child Nutr. 2011, 8, 1–18.
    7. Gardner, W.; Kassebaum, N. Global, Regional, and National Prevalence of Anemia and Its Causes in 204 Countries and Territories, 1990–2019. Curr. Dev. Nutr. 2020, 4, 830.
    8. Instituto Nacional de Estatística (INE). Moçambique—Inquérito Demográfico e de Saúde. 2011. Available online: (accessed on 5 May 2021).
    9. Ministério da Agricultura e Segurança Alimentar (MASA). Impacto Social e Económico da Desnutrição Infantil No Desenvolvimento a Longo Prazo de Moçambique. Secretariado Técnico de Segurança Alimentar e Nutricional. 2017. Available online: (accessed on 5 May 2021).
    10. Anemia Working Group Portugal (AWGP). A Problemática da Anemia Na Sociedade Portuguesa. 2019. Available online: (accessed on 7 May 2021).
    11. World Health Organization. Global Health Observatory Data Repository: By Category, Anaemia in Pregnant Women—Estimates by Country. 2021. Available online: (accessed on 6 May 2021).
    12. World Health Organization. Global Health Observatory Data Repository: By Category, Anaemia in Children—Estimates by Country. 2021. Available online: (accessed on 6 May 2021).
    13. World Health Organization (WHO). Evidence-Based Nutrition Interventions Included in the WHO e-Library of Evidence for Nutrition Actions (eLENA) that May Contribute to the Achievement of the WHO Global Nutrition and Diet-Related NCD Targets Global Nutrition Targets 2025 Global NCD Targets. 2018. Available online: (accessed on 6 May 2021).
    14. World Health Organization (WHO). Interventions by Global Target. 2018. Available online: (accessed on 7 May 2021).
    15. Balarajan, Y.; Ramakrishnan, U.; Ozaltin, E.; Shankar, A.H.; Subramanian, S.V. Anaemia in low-income and middle-income countries. Lancet 2011, 378, 2123–2135.
    16. Black, R.E.; Victora, C.G.; Walker, S.P.; Bhutta, Z.A.; Christian, P.; de Onis, M.; Ezzati, M.; Grantham-McGregor, S.; Katz, J.; Martorell, R.; et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013, 382, 427–451.
    17. Vos, T.; Barber, R.M.; Bell, B.; Bertozzi-Villa, A.; Biryukov, S.; Bolliger, I.; Charlson, F.; Davis, A.; Degenhardt, L.; Dicker, D.; et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386, 743–800.
    18. Vos, T.; Allen, C.; Arora, M.; Barber, R.M.; Bhutta, Z.A.; Brown, A.; Carter, A.; Casey, D.C.; Charlson, F.J.; Chen, A.Z.; et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1545–1602.
    19. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390, 1211–1259.
    20. Diaz, V.; Abalos, E.; Carroli, G. Methods for blood loss estimation after vaginal birth. Cochrane Database Syst. Rev. 2018, 2018, CD010980.
    21. González, R.; Pons-Duran, C.; Piqueras, M.; Aponte, J.J.; Ter Kuile, F.; Menéndez, C. Mefloquine for preventing malaria in pregnant women. Cochrane Database Syst. Rev. 2018, 3, CD011444.
    22. Radeva-Petrova, D.; Kayentao, K.; Ter Kuile, F.O.; Sinclair, D.; Garner, P. Drugs for preventing malaria in pregnant women in endemic areas: Any drug regimen versus placebo or no treatment. Cochrane Database Syst. Rev. 2014, 10, 1–120.
    23. Da Costa, A.G.; Vargas, S.; Clode, N.; Graça, L.M. Prevalence and Risk Factors for Iron Deficiency Anemia and Iron Depletion during Pregnancy: A Prospective Study. Acta Médica Port. 2016, 29, 514.
    24. Mavale, S.; Alburqueque, O.; Mondlane, R.; Guerra, A. Prevalência de anemia numa população infantil da Cidade de Maputo. Acta Pediatr. Port 2000, 31, 33–39.
    25. De Andrade, C.C.; Rodrigues, S.L.; Carneiro, B.N.; Ferreira, M.D. Iron deficiency anemia in adolescents; a literature review. Nutr. Hosp. 2014, 6, 1240–1249.
    26. Ferrari, M.; on behalf of the HELENA Study Group; Mistura, L.; Patterson, E.; Sjostrom, M.; Díaz, L.E.; Stehle, P.; Gonzalez-Gross, M.; Kersting, M.; Widhalm, K.; et al. Evaluation of iron status in European adolescents through biochemical iron indicators: The HELENA Study. Eur. J. Clin. Nutr. 2011, 65, 340–349.
    27. Moreno, L.A. Adolescence. In Pediatric Nutrition in Practice; Koletzko, B., Ed.; Karger Publishers: Basel, Switzerland, 2008; pp. 114–117.
    28. Wharton, B.; Wharton, P. Nutrition in Adolescence. Nutr. Health 1987, 4, 195–203.
    29. Langer, A.; Meleis, A.; Knaul, F.M.; Atun, R.; Aran, M.; Arreola-Ornelas, H.; Bhutta, Z.A.; Binagwaho, A.; Bonita, R.; Caglia, J.M.; et al. Women and Health: The key for sustainable development. Lancet 2015, 386, 1165–1210.
    30. Forouzanfar, M.H.; Alexander, L.; Bachman, V.F.; Biryukov, S.; Brauer, M.; Casey, D.; Coates, M.M.; Delwiche, K.; Estep, K.; Frostad, J.J.; et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386, 2287–2323.
    31. Anemia Working Group Portugal (AWGP). Anemia: Conheça o Problema Que Afeta Os Adolescentes. 2019. Available online: (accessed on 7 May 2021).
    32. Moreira, I.M. Anemia em Adolescentes, Prevalência e Factores Associados: O Papel do Helicobacter Pylori. (Tese de Mestrado). Universidade do Porto, Faculdade de Medicina, Instituto de Ciências Biomédicas Abel Salazar. 2010. Available online: (accessed on 12 May 2021).
    33. Grupo de Eritropatología de la Sociedad Española de Hematología y Hemoterapia (SEHH). El 20% de las Mujeres en Edad Fértil, el 40% de las Gestantes y el 15% de los Adolescentes Tienen Anemia Ferropénica en España. 2018. Available online: (accessed on 28 October 2021).
    34. Hall, A.; Bobrow, E.; Brooker, S.; Jukes, M.; Nokes, K.; Lambo, J.; Guyatt, H.; Bundy, D.; Adjei, S.; Wen, S.T.; et al. Anaemia in schoolchildren in eight countries in Africa and Asia. Public Health Nutr. 2001, 4, 749–756.
    35. Gakidou, E.; Afshin, A.; Abajobir, A.A.; Global Burden Diseases (GBD 2016) Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 10100, 1345–1422.
    36. Duncan, B. Global Child Health: Promises Made to Children—Not Yet Kept. Adv. Pediatr. 2009, 56, 301–339.
    37. Habib, N.; Abbasi, S.-U.S.; Aziz, W. An Analysis of Societal Determinant of Anemia among Adolescent Girls in Azad Jammu and Kashmir, Pakistan. Anemia 2020, 2020, 1–9.
    38. Caetano, J.S.; Azevedo, J.; Saturnino, H.; Manco, L.; Benedito, M.; Bento, C.; Ribeiro, M.L. Défice de glicose-6-fosfato desidrogenase: Breve revisão teórica a propósito de um caso clínico. Saude-Infant 2015, 2, 58–63.
    39. Neves, A.L.; Guimarães, A.I.; Rolão, C. Suplementação preventiva com ferro oral em grávidas não anémicas. Acta Obs. Ginecol. Port 2012, 1, 16–19.
    40. Macedo, A.; Cardoso, S. Suplementação de rotina com ferro na gravidez. Acta Med. Port 2010, 5, 785–792.
    41. Nascimento, P.; Oliveira, M.; Simão, T.S.; Dias, A.; Ferreira, C. Hábitos alimentares em idade pré-escolar. Saude-Infant 2010, 2, 83–88.
    42. Valente, I.; Lima, R.; Antunes, M.; Barbot, J.; Pereira, F. Gastrite atrófica auto-imune—Anemia refractária ao ferro oral. ENDO-News 2010, 30, 14–16.
    43. Vilan, A.; Cunha, J.; Brandão, C.; Cleto, E. Anemia de Diamond-Blackfan. Acta Pediatr. Port 2008, 2, 72–74.
    44. The Global Goals (TGG). The Global Goals for Sustainable Development. Global Goals. Available online: (accessed on 28 October 2021).
    45. Universal Health Coverage (UHC2030). UHC2030: Our Mission. Available online: (accessed on 28 October 2021).
    46. Worldbank (WB). Data for Portugal, Mozambique. Available online: (accessed on 28 October 2021).
    47. Malta, D.C.; Cardoso, L.M.; Teixeira, R.A.; de Carvalho, Q.H.; Ribeiro, A.P.; de Freitas, P.C.; Hartz, Z. Avaliação das metas dos Objetivos de Desenvolvimento Sustentável relacionadas à saúde nos países de língua portuguesa. Evaluation of the health-related targets of the Sustainable Development Goals in Portuguese-speaking countries. An. Do IHMT 2019, 18, 30–41.
    48. Costa, C.; Santana, P.; Dimitroulopoulou, S.; Burström, B.; Borrell, C.; Schweikart, J.; Dzúrová, D.; Zangarini, N.; Katsouyanni, K.; Deboosere, P.; et al. Population Health Inequalities Across and Within European Metropolitan Areas through the Lens of the EURO-HEALTHY Population Health Index. Int. J. Environ. Res. Public Health 2019, 16, 836.
    Subjects: Others
    Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : , ,
    View Times: 266
    Revisions: 2 times (View History)
    Update Date: 20 Apr 2022
    Table of Contents


      Are you sure you want to delete?

      Video Upload Options

      Do you have a full video?
      If you have any further questions, please contact Encyclopedia Editorial Office.
      Cane, R.M.; Chidassicua, J.; Craveiro, I. Anemia in Pregnant Women and Children. Encyclopedia. Available online: (accessed on 07 February 2023).
      Cane RM, Chidassicua J, Craveiro I. Anemia in Pregnant Women and Children. Encyclopedia. Available at: Accessed February 07, 2023.
      Cane, Réka Maulide, Jose Chidassicua, Isabel Craveiro. "Anemia in Pregnant Women and Children," Encyclopedia, (accessed February 07, 2023).
      Cane, R.M., Chidassicua, J., & Craveiro, I. (2022, April 19). Anemia in Pregnant Women and Children. In Encyclopedia.
      Cane, Réka Maulide, et al. ''Anemia in Pregnant Women and Children.'' Encyclopedia. Web. 19 April, 2022.